APLT: Applied Therapeutics, Inc. Stock

by  •  • Comments Off on APLT: Applied Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 43.24
Enterprise Value ($M) -55.63
Book Value ($M) 5.89
Book Value / Share 0.05
Price / Book 7.34
NCAV ($M) 3.93
NCAV / Share 0.03
Price / NCAV 11.00

Profitability (mra)
Return on Invested Capital (ROIC) -23.82
Return on Assets (ROA) -1.24
Return on Equity (ROE) -2.78

Liquidity (mrq)
Quick Ratio 1.06
Current Ratio 1.06

Balance Sheet (mrq) ($M)
Current Assets 104.60
Assets 106.57
Liabilities 100.67
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Perceptive Advisors Llc 2.40 -71.41
02-14 13G/A Venrock Healthcare Capital Partners III, L.P. 9.90
02-14 13G/A Janus Henderson Group Plc 0.00
02-14 13G Vestal Point Capital, LP 9.90 904.37
02-14 13G Schonfeld Strategic Advisors LLC 7.54
02-14 13G Alyeska Investment Group, L.P. 5.76 34.64
02-07 13G/A Morgan Stanley 2.50
02-05 13G/A BlackRock, Inc. 8.00 33.90
01-27 13G/A Franklin Resources Inc 1.70
11-13 13G/A Alexandria Real Estate Equities, Inc. 10.30 -2.33
08-14 13D/A Shendelman Shoshana 6.60 -9.76

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-15 10-K In light of the significant uncertainties in these forward-looking statements, you should not rely upon forward-looking statements as predictions of future events. Although we believe that we have a reasonable basis for each forward-looking statement
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-14 397,518 1,136,575 34.98
2025-04-11 399,471 1,431,019 27.92
2025-04-10 398,280 1,206,894 33.00
2025-04-09 1,761,362 4,433,161 39.73

(click for more detail)

Similar Companies
ALT – Altimmune, Inc. ANIP – ANI Pharmaceuticals, Inc.
APGE – Apogee Therapeutics, Inc. AQST – Aquestive Therapeutics, Inc.
ARCT – Arcturus Therapeutics Holdings Inc.


Financial data and stock pages provided by
Fintel.io